Intranasal immunization with a single dose of the fusion protein formulated with a combination adjuvant induces long-term protective immunity against respiratory syncytial virus-Reference-Cited by-同舟云学术

Intranasal immunization with a single dose of the fusion protein formulated with a combination adjuvant induces long-term protective immunity against respiratory syncytial virus

Published:2017-08-21 Issue:12 Volume:13 Page:2894-2901
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Garg R.¹,Latimer L.¹,Gerdts V.¹²,Potter A.¹²,van Drunen Littel-van den Hurk S.¹³

Affiliation:

1. VIDO-InterVac, University of Saskatchewan, Saskatoon, SK, Canada

2. Veterinary Microbiology, University of Saskatchewan, Saskatoon, SK, Canada

3. Microbiology and Immunology, University of Saskatchewan, Saskatoon, SK, Canada

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2017.1349584

Reference36 articles.

1. Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults

2. Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants

3. RESPIRATORY SYNCYTIAL VIRUS DISEASE IN INFANTS DESPITE PRIOR ADMINISTRATION OF ANTIGENIC INACTIVATED VACCINE12

4. Viral and Host Factors in Human Respiratory Syncytial Virus Pathogenesis

5. Comparison of the ability of formalin-inactivated respiratory syncytial virus, immunopurified F, G and N proteins and cell lysate to enhance pulmonary changes in Balb/c mice

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Inhaled Nanoformulations of Vaccines and Therapeutics Targeting Respiratory Viral Infections;Pharmaceutical Research;2023-04-25

2. Polyphosphazene: A New Adjuvant Platform for Cocaine Vaccine Development;Molecular Pharmaceutics;2022-08-19

3. Assessing the In Vivo Effectiveness of Cationic Lipid Nanoparticles with a Triple Adjuvant for Intranasal Vaccination against the Respiratory Pathogen Bordetella pertussis;Molecular Pharmaceutics;2022-03-18

4. Polyphosphazenes as Adjuvants for Animal Vaccines and Other Medical Applications;Frontiers in Bioengineering and Biotechnology;2021-03-04

5. Polyphosphazene immunoadjuvants: Historical perspective and recent advances;Journal of Controlled Release;2021-01